Glioblastoma Clinical Trial with Phase One Foundation | Santosh Kesari, MD, PhD 

PHASE ONE Foundation provided the initial funding for a breakthrough clinical trial for patients with brain cancer. The trial’s principal investigator and author Santosh Kesari, MD, PhD, conducts the study at Pacific Neuroscience Institute, Saint John’s Cancer Institute and Providence Saint John’s Health Center.
Called the Precision Immunotherapy in the Neoadjuvant Setting (PIN) trial, this study provides an alternative immunotherapy option to the current standard of care treatment that patients receive when presenting with a new diagnosis of glioblastoma.
Find out more:
310-829-8265 | Neuro.oncology@providence.org
www.pacificneuroscienceinstit...
PHASE ONE Foundation:
www.phaseonefoundation.org/